Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma

Many drugs that show potential in animal models of glioblastoma (GBM) fail to translate to the clinic, contributing to a paucity of new therapeutic options. In addition, animal model development often includes histologic assessment, but multiparametric/multimodality imaging is rarely included despit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Luke R., Masi, Megan R., Selman, Bryce M., Sandusky, George E., Zarrinmayeh, Hamideh, Das, Sudip K., Maharjan, Surendra, Wang, Nian, Zheng, Qi-Huang, Pollok, Karen E., Snyder, Scott E., Sun, Phillip Zhe, Hutchins, Gary D., Butch, Elizabeth R., Veronesi, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722958/
https://www.ncbi.nlm.nih.gov/pubmed/36483050
http://dx.doi.org/10.3389/fonc.2022.939260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722958/
https://www.ncbi.nlm.nih.gov/pubmed/36483050
http://dx.doi.org/10.3389/fonc.2022.939260

Ejemplares similares